Search keyWord :

Milken Institute Unveils Global Dinner Dialogues, Spotlighting South Korea at the Crossroads

Mar 13, 2025

As the Institute\'s first convening in South Korea,the event will gather prominent business leaders and global investors to examine the country\'s economic outlook and investment opportunities

Casual Brings Comprehensive Corporate Video Content Solutions to Shenzhen

Mar 13, 2025

SHENZHEN,China,March 13,2025-- Casual,a leading global video production company known for award-winning content and storytelling,proudly announces theopening of its first Mainland China office,凯视,in

TVU Networks Celebrates 20 Years of Innovation at NAB 2025

Mar 13, 2025

Company to Showcase AI Offerings and Expanded Cloud Ecosystem. CUPERTINO,Calif.,March 13,2025-- TVU Networks,a pioneer in live video production and a leader in cloud-based media solutions,is marking i

Xinhua Silk Road: E. China's Quanzhou City rides cultural revival wave to tourism boom

Mar 13, 2025

BEIJING,March 13,2025-- Quanzhou,a historic coastal city in southeast China\'s Fujian Province,saw robust tourism growth during the 2025 Spring Festival holiday,with 10.12 million visits and tourism r

Caliber Launches 4 Analytics and AI-driven Solutions to Revolutionize Pharma Manufacturing and Quality

Mar 13, 2025

PITTSBURGH,March 13,2025-- Caliber recently launched 4 digital solutions that further strengthen its portfolio and also position the company at the forefront of the Pharma 4.0 revolution. These innov

Ping An Health Reports First Full-Year Profit in 2024

Mar 13, 2025

Synergies Between Health Care and Insurance Drive Scalable Growth AI Innovations Fuel Continued Success

Copute Partners The Ignition AI Accelerator, a Collaboration Among NVIDIA, Tribe, and DISG, Drive Innovations in Decentralised AI

Mar 13, 2025

SINGAPORE,March 13,2025-- The Ignition AI Accelerator,a collaboration between NVIDIA,Tribe,and Digital Industry Singapore (DISG),announces its partnership with Copute,a pioneering Web3 ecosystem dedic

GC Cell Initiates First Patient Dosing in Phase 1 Clinical Trial for GCC2005, a Promising T‑Cell Lymphoma CD5 CAR-NK Therapy

Mar 13, 2025

YONGIN,South Korea,March 13,2025-- GC Cell (KRX:144510),under the leadership of CEO Sungyong Won,announced today the initiation of its domestic Phase 1 clinical trial for GCC2005 (AB‑205),a novel CD

Palo Alto Networks Deepens Commitment in Asia-Pacific and Japan with New Cloud Infrastructure Investment

Mar 13, 2025

Prisma Access Browser to integrate into existing infrastructure across strategic locations in Asia-Pacific and Japan,to support customer\'s data residency needs

STEQEYMA® (ustekinumab-stba), a biosimilar to STELARA® (ustekinumab), now available in the United States

Mar 13, 2025

STEQEYMA®,one of the first-wave biosimilars to STELARA®,is now available in the U.S. Approved for the same indications as the reference product,STEQEYMA will be priced with a wholesale acquis

1 ... 159 160 161 162 163 164 165 ... 1285